Close Menu

equity investment

With its recent $50 million VC round, the British bioinformatics firm is targeting growth in new applications as it accelerates tertiary data analysis.

The British bioinformatics firm expects to move into somatic cancer and wellness programs, as well as widen its geographic footprint.

With the new funding, the informatics and small-panel genetic testing firm looks to expand its IT capabilities and offer new DTC screening tests.

The Swiss-American bioinformatics company touts its networks of multimodal data and numerous partnerships as it looks to support "data-driven medicine."

The Swiss-American bioinformatics company has now raised more than $250 million and seeks to further expand expand deeper in the US and Asian markets. 

The firm added $50 million from Casdin Capital, Danaher Life Sciences, and Agilent Technologies to its $38.5M Series B round announced in May 2019.

BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.

Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.

Sanford Health will help validate TruGenomix's TruGen-1 post-traumatic stress disorder test through its Imagenetics clinical genomics program.

The initial investment is led by Debiopharm, which will collaborate with the Israeli startup to accelerate discovery of biomarkers for oncology drug response.

Pages

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.